Fraud, Lies, Exploitation and Eugenic Fantasies
By Emile P. Torres,
Truthdig
| 11. 09. 2023
It’s been a no good, very bad year for Effective Altruism, or “EA” for short, the cultural movement that aims to use “evidence and reason” to figure out the best ways to do the “most good.”
One year ago, the EA community was flying high. Its poster boy, a philosopher named William MacAskill, had just published his book “What We Owe the Future,” which makes the case that we should be far more concerned about humanity’s long-term future — thousands, millions, even billions of years from now — than we ordinarily are. Effective Altruists call this “longtermism,” an idea built around a vision of the future in which we reengineer humanity, colonize space, plunder the vast resources of the cosmos, and ultimately maximize the total amount of “value” in the universe by creating huge numbers of “digital people” living “happy” lives in giant computer simulations.
If this sounds bizarre and potentially dangerous, that’s because it is. Yet MacAskill’s book, longtermism and the EA movement that he co-founded received mostly favorable coverage from...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...